Holdings of Bain Capital Life Sciences Investors, LLC
16 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 90.6 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 16 | 775.8M $ | 100.00 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| HeartFlow Inc | 10,448,158 | 254.2M $ | |
| Olema Pharmaceuticals Inc | 7,473,238 | 111.4M $ | |
| Savara Inc | 17,600,621 | 96.1M $ | |
| Solid Biosciences Inc | 9,808,819 | 70.6M $ | |
| X4 PHARMACEUTICALS INC | 7,967,454 | 32.9M $ | |
| Dianthus Therapeutics Inc | 362,470 | 30.4M $ | |
| Annexon Inc | 5,212,674 | 28.9M $ | |
| Kyverna Therapeutics Inc | 3,110,000 | 26.8M $ | |
| Cabaletta Bio Inc | 9,677,125 | 26M $ | |
| CENTESSA PHARMACEUTICALS PLC | 635,000 | 25.2M $ | |
| Rapid Micro Biosystems Inc | 8,434,560 | 19.1M $ | |
| C4 Therapeutics Inc | 7,171,910 | 18.9M $ | |
| Atea Pharmaceuticals Inc | 2,360,638 | 12.7M $ | |
| Disc Medicine Inc | 141,234 | 9M $ | |
| Upstream Bio Inc | 867,211 | 7.8M $ | |
| Xilio Therapeutics Inc | 664,021 | 5.6M $ |